FDA Approval Activities for this Drug…

Coreg (carvedilol) Tablets, 3.125, 6.25, 12.5 and 25 mg GlaxoSmithKline NDA 20297/S011 9/29/03 9/30/03 Coreg (Carvedilol) Tablets, 3.125mg, 6.25mg, 12.5mg, & 25mg. GlaxoSmithKline NDA 20297/S009 3/27/03 4/1/03 7/8/03 Coreg (Carvedilol) Tablets, 3.125mg, 6.25mg, 12.5mg, & 25mg. GlaxoSmithKline NDA 20297/S007 11/1/01 3/28/02 3/28/02 3/28/02 Coreg (Carvedilol) Tablets, 3.125mg, 6.25mg, 12.5mg, & 25mg. SmithKline Beecham NDA 20297/S004 Carvedilol Tablets, TEVA Pharmaceuticals | Carvedilol Tablet, Ranbaxy, Tentative Approval | Coreg (carvedilol) Tablets, GlaxoSmithKline, New or Modified Indication

For the latest approval information, please locate this drug using this index.